Symptomatic and tachycardiac supraventricular arrhythmias requiring treatment such as: A-V-junctional tachycardia, supraventricular tachycardia associated with Wolff Parkinson-White syndrome or, paroxysmal atrial fibrillation.
This indication applies to patients who do not respond to other antiarrhythmics or for whom antiarrhythmics are not indicated: Severe symptomatic tachycardiac ventricular arrhythmias.
It should be noted that a therapy with beta-blockers should not be stopped in favour for a treatment with amiodarone.